Simplex Trading
EDIT icon

Simplex Trading’s Editas Medicine EDIT Stock Holding History

Simplex Trading’s Portfolio EDIT Stock Details EDIT Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q2 		$207K Buy
63,974
+57,993
+970% +$169K ﹤0.01% 4672
2026
Q1 		$14.8K Sell
5,981
-133,791
-96% -$283K ﹤0.01% 7009
2025
Q4 		$287K Sell
139,772
-92,091
-40% -$266K ﹤0.01% 3865
2025
Q3 		$804K Buy
231,863
+95,406
+70% +$266K ﹤0.01% 3275
2025
Q2 		$300K Buy
136,457
+2,290
+2% +$3.75K ﹤0.01% 4066
2025
Q1 		$155K Buy
134,167
+95,525
+247% +$141K ﹤0.01% 4596
2024
Q4 		$49K Sell
38,642
-12,734
-25% -$32.4K ﹤0.01% 5883
2024
Q3 		$175K Sell
51,376
-18,916
-27% -$82.3K ﹤0.01% 4649
2024
Q2 		$328K Buy
70,292
+42,826
+156% +$242K ﹤0.01% 4125
2024
Q1 		$203K Buy
+27,466
New +$228K ﹤0.01% 4840
2023
Q4 		– Sell
-25,507
Closed -$224K – 9014
2023
Q3 		$198K Buy
25,507
+12,851
+102% +$110K ﹤0.01% 4367
2023
Q2 		$104K Buy
12,656
+7,360
+139% +$64.1K ﹤0.01% 5038
2023
Q1 		$38K Buy
+5,296
New +$47.1K ﹤0.01% 6229
2022
Q4 		– Sell
-41,268
Closed -$453K – 9449
2022
Q3 		$505K Buy
+41,268
New +$643K ﹤0.01% 3460
2022
Q1 		– Sell
-28,796
Closed -$535K – 10599
2021
Q4 		$764K Sell
28,796
-67,080
-70% -$2.31M ﹤0.01% 3241
2021
Q3 		$5.42M Buy
95,876
+423
+0.4% +$23.2K 0.01% 1128
2021
Q2 		$5.41M Buy
95,453
+16,805
+21% +$621K 0.01% 1113
2021
Q1 		$0 Buy
+78,648
New +$4.48M ﹤0.01% 9076
2020
Q4 		– Sell
-6,730
Closed -$276K – 8498
2020
Q3 		$188K Sell
6,730
-9,425
-58% -$307K ﹤0.01% 4190
2020
Q2 		$477K Sell
16,155
-66,429
-80% -$1.74M ﹤0.01% 2969
2020
Q1 		$1.64M Buy
82,584
+59,489
+258% +$1.5M ﹤0.01% 1442
2019
Q4 		$683K Buy
23,095
+19,130
+482% +$478K ﹤0.01% 2427
2019
Q3 		$90K Buy
+3,965
New +$98.2K ﹤0.01% 4434
2019
Q2 		– Sell
-17,148
Closed -$409K – 7251
2019
Q1 		$419K Buy
17,148
+15,538
+965% +$352K ﹤0.01% 2838
2018
Q4 		$36K Sell
1,610
-12,497
-89% -$340K ﹤0.01% 4835
2018
Q3 		$448K Sell
14,107
-10,775
-43% -$348K ﹤0.01% 2744
2018
Q2 		$891K Sell
24,882
-6,178
-20% -$219K ﹤0.01% 1902
2018
Q1 		$1.03M Buy
31,060
+19,175
+161% +$683K 0.05% 384
2017
Q4 		$365K Buy
11,885
+1,822
+18% +$45.9K 0.02% 881
2017
Q3 		$241K Sell
10,063
-32,867
-77% -$626K 0.01% 1070
2017
Q2 		$720K Buy
42,930
+32,108
+297% +$579K 0.03% 486
2017
Q1 		$241K Buy
10,822
+4,036
+59% +$83.6K 0.01% 1101
2016
Q4 		$110K Sell
6,786
-1,800
-21% -$27.3K 0.01% 1455
2016
Q3 		$115K Buy
+8,586
New +$176K 0.01% 1425

Other funds holding EDIT

TCM
TCG Crossover Management Palo Alto, California $4.16B AUM 983.43% 1-Year Est. Return
BlackRock
BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return
ACM
ADAR1 Capital Management Austin, Texas $2.19B AUM 374.99% 1-Year Est. Return
CC
Commodore Capital New York $1.68B AUM 375.52% 1-Year Est. Return
RCM
RA Capital Management Boston, Massachusetts $11.5B AUM 168.77% 1-Year Est. Return
Vanguard Capital Management
Vanguard Capital Management Malvern, Pennsylvania $4.68T AUM
PBA
Paradigm Biocapital Advisors New York $5.34B AUM 380.18% 1-Year Est. Return
OM
Opaleye Management Boston, Massachusetts $1.1B AUM 197.64% 1-Year Est. Return
Vanguard Portfolio Management
Vanguard Portfolio Management Malvern, Pennsylvania $2.22T AUM
WP
Woodline Partners San Francisco, California $32.4B AUM 58.5% 1-Year Est. Return

Simplex Trading's EDIT Position: Q2 2026 in Review

Simplex Trading increased its Editas Medicine (EDIT) stake by 970% in Q2 2026, buying an estimated $169K and bringing the position to 63,974 shares worth $207K. The position accounts for ﹤0.01% of the portfolio, ranked #4672.

Simplex Trading first reported a position in EDIT in Q3 2016 and has held it in 34 quarters since. The position peaked at $5.42M in Q3 2021. 214 funds tracked by Wall St. Rank hold EDIT as of Q2 2026.

  • Simplex Trading held 63,974 shares of Editas Medicine worth $207K as of Q2 2026.
  • Simplex Trading bought 57,993 Editas Medicine shares in Q2 2026, an estimated $169K.
  • Editas Medicine made up ﹤0.01% of Simplex Trading's portfolio in Q2 2026, its #4672 holding.
  • Simplex Trading first reported a position in Editas Medicine in Q3 2016 and has held it in 34 quarters since.
  • Simplex Trading's Editas Medicine position peaked at $5.42M in Q3 2021.
  • 214 funds tracked by Wall St. Rank held Editas Medicine as of Q2 2026.

Based on Simplex Trading's 13F filing for Q2 2026, filed 12 Aug 2026.